Christine Lemke
SVP, Portfolio & Growth Strategy
Professional Overview
Christine Lemke is an accomplished senior executive with extensive experience in strategic portfolio management, corporate development, and R&D planning across the pharmaceutical and biotechnology industries. As the SVP of Portfolio & Growth Strategy at Absci, she is responsible for driving the company's long-term strategic vision, identifying new growth opportunities, and optimizing the product portfolio to maximize value.
Experience Summary
Current Role
In her current role at Absci, Christine is responsible for shaping the company's portfolio and growth strategies, evaluating new market opportunities, and leading cross-functional initiatives to accelerate the commercialization of Absci's innovative platform technologies. She works closely with the executive team to align the organization's resource allocation and investment decisions with the company's long-term objectives.
Career Progression
Prior to joining Absci, Christine served as the Head of Global Corporate Development at Ferring International Center SA, where she led the company's strategic planning, mergers and acquisitions, and business development efforts. She has also held senior roles at Takeda, Shire, and Bayer, where she was responsible for driving R&D strategy, portfolio management, and corporate strategy initiatives.
Throughout her career, Christine has demonstrated a strong track record of identifying and capitalizing on emerging market trends, driving organizational transformation, and delivering measurable business impact. Her deep understanding of the pharmaceutical and biotechnology industries, coupled with her strategic vision and collaborative leadership style, have made her a trusted advisor to C-suite executives and key stakeholders.
Academic Background
Christine holds a Ph.D. in Biochemistry from the University of Cambridge and a Master's degree in Chemistry from the University of Oxford. She has published numerous articles in peer-reviewed scientific journals and is recognized as a thought leader in the field of biopharmaceutical development and commercialization.
Areas of Expertise
- Strategic portfolio management
- Corporate development and M&A
- R&D planning and optimization
- Market assessment and opportunity identification
- Cross-functional team leadership
- Stakeholder engagement and communication
Professional Impact
During her tenure at Ferring, Christine spearheaded the company's expansion into new therapeutic areas, leading to the successful integration of several strategic acquisitions. At Bayer, she played a pivotal role in the organization's transformation, aligning the R&D pipeline and commercial strategies to drive sustainable growth.
Conclusion
With her exceptional track record of success, Christine Lemke is poised to make a significant impact on Absci's growth trajectory. Her deep industry expertise, strategic vision, and collaborative leadership style make her a valuable asset to the organization as it continues to push the boundaries of innovation in the biotechnology sector.
